Skin Elements Faces Boardroom Challenge as Shareholder Seeks Director’s Removal

Skin Elements Limited ( (AU:SKN) ) just unveiled an update.

Skin Elements Limited has received a shareholder requisition under section 249D of the Corporations Act from Kingsbury Wealth Pty Ltd, which holds 7.3% of the company’s shares and is controlled by director Roderick Nicholas, calling for a general meeting to vote on the removal of fellow director Filippo (Phil) Giglia. The board is currently reviewing the notice and seeking advice, with the outcome potentially altering the company’s board composition and governance dynamics, and has committed to updating shareholders in line with ASX listing requirements.

The move by a significant shareholder linked to an existing director underscores underlying tensions within the company’s leadership and could signal a shift in strategic direction depending on the meeting’s outcome. Investors and other stakeholders will be watching closely, as any board changes may affect decision-making around the commercialisation of Skin Elements’ product portfolio and its positioning within the competitive biotech and natural personal care sectors.

The most recent analyst rating on (AU:SKN) stock is a Sell with a A$0.01 price target. To see the full list of analyst forecasts on Skin Elements Limited stock, see the AU:SKN Stock Forecast page.

More about Skin Elements Limited

Skin Elements Limited (ASX: SKN) is an Australian-owned, ASX-listed biotechnology healthcare company focused on commercialising its proprietary anti-microbial SE Formula through natural and organic health care products. Its portfolio includes plant-based and TGA-registered offerings such as SuprCuvr hospital-grade disinfectant, Eco Nurture plant bio-stimulant, Invisi Shield sanitiser, Soléo Organics sunscreen, PapayaActivs skincare and the Elizabeth Jane Natural Cosmetics brand, with products distributed globally.

Current Market Cap: A$12M

See more data about SKN stock on TipRanks’ Stock Analysis page.